Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02396810 · ClinicalTrials.gov registry record · NA
Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02396810 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT02396810, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators are studying the utility of intra-operative magnetic resonance imaging (iMRI) during transsphenoidal pituitary surgery for large macroadenomas by randomizing patients to either an intra-operative MRI after resection, or no intra-operative MRI. The investigators will then count the number of gross total resection in each group of patients and also the complications related to surgery.
Interventions
- OTHER intra-operative MRI
- PROCEDURE Transsphenoidal resection of pituitary macroadenoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-05-19 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02396810
The ClinicalTrials.gov registry entry for NCT02396810 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which intra-operative MRI is the first listed.
NCT02396810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02396810 about?
NCT02396810 is a clinical study titled "Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas". The investigators are studying the utility of intra-operative magnetic resonance imaging (iMRI) during transsphenoidal pituitary surgery for large macroadenomas by randomizing patients to either an intra-operative MRI after resection, or no intra-operative MRI. The investigators will then count the ...
What is the current status of trial NCT02396810?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2015-05-19. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT02396810?
The interventions under investigation include: intra-operative MRI (OTHER), Transsphenoidal resection of pituitary macroadenoma (PROCEDURE).
Who is sponsoring clinical trial NCT02396810?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.